Risperidone-related bilateral cystoid macular oedema.
Kleanthis
K
Manousaridis
Rajen
R
Gupta
D000368:Aged; D000420:Albuterol / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D018967:Risperidone / Q000009:adverse effects*; D012602:Scopolamine Derivatives / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000009:adverse effects*; D000069447:Tiotropium Bromide; D041623:Tomography, Optical Coherence
D014150:Antipsychotic Agents; D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D012702:Serotonin Antagonists; D018967:Risperidone; D000420:Albuterol; D000069447:Tiotropium Bromide